In this podcast, Ahmed Elhakeem, MPH, PhD, talks about how time spent in various physical activity levels throughout adolescence impacts peak bone strength and osteoporosis risk later in...
Clifford Rosen, MD, chair of the Endocrine Society's 2019 clinical practice guideline for the pharmacological management of osteoporosis in postmenopausal women, reviews key points of the new guideline. ...
International Menopause Society President Susan Davis, PhD, discusses key points from the latest consensus statement on the use of testosterone therapy in women. The statement has been endorsed by various...
Maria Fleseriu, MD, discusses reproductive assistance options that can be pursued in patients with hypopituitarism who want to become pregnant, how endocrinologists can best navigate prescribing appropriate...
Dr Speiser answers our questions about the Endocrine Society’s 2018 clinical practice guideline for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency.
Dr Matera reviews recent evidence that has demonstrated the potential renal protection offered by sodium glucose co-transporter 2 inhibitors against diabetic kidney disease.
Neal Barnard, MD, President of the Physicians Committee for Responsible Medicine, discusses evidence on the key role of plant-based eating patterns in the treatment of diabetes, as well as the importance of...
Kim Carmichael, MD, from the Washington University School of Medicine in St. Louis, discusses his column, “What Do You Need to Know About Diabetic Gastroparesis?”
In this podcast, Lucia Novak reflects on how the ACP's 2018 HbA1c guidelines have impacted the landscape of diabetes care over the past year, and discusses the importance of individualized treatment.
Lucia Novak, director of Riverside Diabetes Center, gives strategies that may help improve diabetes management and prevent clinical inertia on patient and practitioner levels.
